|Resources|Knowledge Center| HPLC Knowledge Center|Understanding Peak Fronting in HPLC|

Peak Fronting: The Causes & How to Solve It?

lc column

Peak fronting in high-performance liquid chromatography (HPLC) refers to an asymmetry in the shape of a chromatographic peak, where the front half of the peak (the portion before the apex) is broader or slopes more steeply than the back half. Ideally, chromatographic peaks should be symmetrical, resembling a Gaussian distribution, as this ensures accurate separation and quantification of components in a sample.

However, in peak fronting, the leading edge of the peak appears distorted or "stretched" forward. Such a distortion, where the peak's highest point is shifted toward the beginning of the chromatogram, suggests that some molecules of the compound are eluting sooner than expected.

Causes of HPLC Peak Fronting

Peak fronting can occur due to several factors that disrupt the symmetrical shape of chromatographic peaks, including:

Impacts of Peak Fronting on Chromatographic Results

This technique is used in various pharmaceutical industries due to its ability to separate various types of desired charged molecules. It is widely used for the purification of enzymes, amino acids, proteins, antibodies, simpler carbohydrates, organic compounds, and nucleic acids.

Peak fronting in HPLC can negatively affect chromatographic analyses in several key ways:

Reduction in Peak Height Accuracy

When peak fronting occurs, the height of the peak decreases while maintaining the same overall area. This diminished peak height can lead to an underestimation of the concentration of the analyte in the sample, as the measured height no longer accurately reflects the true amount present.

Complications in Peak Area Measurement

A fronting peak typically features a baseline that is not level, which complicates the accurate determination of where the peak begins and ends. This irregular baseline makes it challenging to precisely calculate the area under the peak, thereby affecting the reliability of quantitative analyses.

Challenges in Detecting Minor Components

The presence of a fronting peak can interfere with the detection of smaller, trace-level peaks that may elute closely ahead of the main band. This overlap can obscure these minor components, making it difficult or even impossible to identify and quantify them accurately within the chromatogram.

HPLC Troubleshooting: Peak Fronting

Check for Column Phase Collapse

The column should be flushed with 100% acetonitrile, and appropriate column phases designed for highly aqueous mobile phases should be utilized to prevent phase collapse.

Match Solvent Composition

The solvent composition of the sample must be aligned with the mobile phase's aqueous–organic ratio to ensure consistent interactions of the analyte.

Reduce Injection Volume

The volume of the injected sample should be decreased to avoid overloading the column, which can distort peak shapes.

Dilute the Sample

The concentration of the analyte should be lowered by diluting the sample, thereby preventing mass overloading and enhancing peak symmetry.

Resolve Coelution Issues

Chromatographic conditions, such as using a slower gradient or adjusting the organic/water ratio, should be modified to separate interfering substances that may cause peak fronting.

Minimize Dead Volume

All tube fittings should be properly seated, and the correct fittings and ferrules should be used to reduce dead volume at the column inlet.

Inspect and Replace Damaged Columns

The column should be examined for any physical damage or anomalies near the inlet, and it should be replaced if necessary to restore proper flow and peak shape.

Get the answers to chromatography peak issues from Phenomenex’s expert troubleshooting guide.

3
Already know which chromatography products you want?
QUICK ORDER
/quick-order
#8853ad

Matt Boag

Global Biopharmaceutical Marketing Manager

Matt Boag is the Global Biopharmaceutical Marketing Manager at Phenomenex, where he leads strategic marketing and product initiatives that empower scientists in the development and characterization of biotherapeutics. With over a decade of experience in the pharmaceutical and biopharmaceutical industries, Matt brings deep expertise in regulatory compliance, analytical chemistry, and process development. He holds a BSc in Biochemistry/Biotechnology and an MSc in Chemistry, combining scientific rigor with commercial insight to drive innovation and customer success.
View LinkedIn Profile